{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=National%20Chemical%20Laboratories","name":"National Chemical Laboratories","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-03T13:35:53.548Z"},"count":1,"matches":[{"id":"f6b01f4aa30f748e","posted_date":"2023-11-21","letter_issue_date":"2023-11-08","company_name":"National Chemical Laboratories","issuing_office":"Office of Pharmaceutical Quality Operations","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/f6b01f4aa30f748e"}]}